Major Depressive Disorder Excellence Forum

Major Depressive Disorder

Excellence Forum

Q&As

Exploring Novel and Accessible Treatment Approaches for Children With Depression, Part 1

07/17/2023

Parco Sui, PhD, associate professor and head of the Kinesiology Division at the University of Hong Kong discusses the results of his study "Physical Activity Interventions to Alleviate Depressive Symptoms in Children and Adolescents."

Parco Sui, PhD, associate...

07/17/2023

Psych Congress Network

Q&As

Using Physical Activity to Improve Adolescents' MDD Symptoms

07/17/2023

In part 2 of this Q&A, Parco Sui, PhD, associate professor and head of the Kinesiology Division at the University of Hong Kong reveals the clinical implications of his study "Physical Activity Interventions to Alleviate Depressive Symptoms in...

In part 2 of this Q&A, Parco...

07/17/2023

Psych Congress Network

Podcasts

Evaluating Treatment Response in Major Depressive Disorder

06/02/2023

Mark Zimmerman, MD, professor of psychiatry and human behavior at Brown University examines how clinicians can best measure patient response to medication or treatment.

Mark Zimmerman, MD, professor of...

06/02/2023

Psych Congress Network

Videos

Are Non-Symptom Factors Worth Consideration When Determining Patient Treatment Response?

10/05/2022

Dr Zimmerman weighs in on the recent research that patients consider non-symptom factors important in evaluating treatment response.

Dr Zimmerman weighs in on the...

10/05/2022

Psych Congress Network

Videos

The Acceptability and Next Steps With the CASSY Suicide Screening Tool

01/24/2022

In the conclusion of this video series, Cheryl King, PhD, professor in the Departments of Psychiatry and Psychology and Director of the Youth Depression and Suicide Prevention Program at the University of Michigan, Ann Arbor, discusses the...

In the conclusion of this video...

01/24/2022

Psych Congress Network

NEW FROM THE NP INSTITUTE ONLINE LEARNING HUB

Rapid Refresh

Navigating Bipolar Disorder Treatment: Exploring the Role of Second-Generation Antipsychotics

04/11/2024

Featuring Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN

Featuring Andrew Penn, MS, PMHNP, and...

Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...

Andrew Penn, MS, PMHNP, and...

04/11/2024

Psych Congress NP Institute

Rapid Refresh

Long-Acting Injectables for Adolescents With Schizophrenia and Schizoaffective Disorder

04/10/2024

Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...

Amber Hoberg, PMHNP-BC,...

04/10/2024

Psych Congress NP Institute

Clinical Pearls

Tolerability Testing in Long-Acting Injectable Prescriptions

04/03/2024

Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.

Major Depressive Disorder Excellence Forum

NEW FROM THE NP INSTITUTE ONLINE LEARNING HUB

Sign Up

Specialties

Events

Year Round Education

HMP Global Products